Trigeminal nerve in trigeminal neuralgia, trigeminal neuropathy and TMJ disorders

August 21, 2013

Advances in MRI imaging have allowed visualizing the trigeminal nerve and a group of Australian researchers reported on their findings in three conditions which cause facial pain. Trigeminal nerve supplies sensation to the face and facial pain of any kind is also transmitted to the brain through this nerve. Their report, which appeared in The Journal of Pain, suggests that imaging trigeminal nerve may help in making a more accurate diagnosis, which is turn may lead to more appropriate treatment.

Trigeminal neuralgia is an extremely painful condition which is characterized by very brief electric-like pains in the face. The pain is triggered by chewing, talking, brushing teeth, touching a specific spot on the face, and at times occurring without any provocation. This condition usually results from compression of the trigeminal nerve by a blood vessel as it exits the brain stem. Treatment usually involves epilepsy drugs, such as carbamazepine (Tegretol) or oxcarbazepine (Trileptal), Botox injections, nerve destruction (radiofrequency thermocoagulation) or if nothing else works, surgery (microvascular decompression of the trigeminal nerve).

Trigeminal neuropathy also causes pain in the face, but it is less intense, usually continuous and is often burning in character. It can result from an injury to the trigeminal nerve in the periphery rather than near the brain stem. Dental procedures and facial injuries can trigger this pain. This pain tends to respond better to antidepressants, such as amitriptyline (Elavil), nortriptyline (Pamelor), protriptyline (Vivactil), and an epilepsy drug, gabapentin (Neurontin).

Temporomandibular joint disorders can result from arthritic changes in this joint, displacement of the cartilaginous disc inside the joint, or from muscle spasm and inflammation around the joint.

Using special MRI techniques the researchers discovered that patients with trigeminal neuralgia had thinning of the nerve, while those with trigeminal neuropathy had thicker trigeminal nerves than normal controls. Patients with temporomandibular disorders had normal thickness of their trigeminal nerves. This is a very useful finding, particularly when the diagnosis is not clear since some patients may have symptoms of both neuralgia and neuropathy. We often have to try several drugs before finding one that is effective and does not cause side effects, so it would be helpful to know from the start which drugs are more likely to work.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe